Merit Medical Systems, Inc. (NASDAQ:MMSI) on Thursday reported upbeat results for the third quarter.

The company posted quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $1.03 per share. The company reported quarterly sales of $416.244 million which beat the analyst consensus estimate of $410.376 million.

Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.25-$4.35 to $4.33-$4.37 and narrowed sales guidance from $1.631 billion-$1.643 billion to $1.635 billion-$1.642 billion.

“Merit delivered third quarter financial results that exceeded the high end of our expectations, driven primarily by 9% organic, constant currency revenue growth, excluding the impact of a strategic divestiture,” said Martha G. Aronson, Merit’s President and CEO.

Merit Medical Systems shares rose 0.1% to $93.40 in pre-market trading

These analysts made changes to their price targets on Merit Medical Systems following earnings announcement.

• BTIG analyst Sam Eiber maintained the stock with a Buy and raised the price target from $105 to $110.
• Needham analyst Mike Matson maintained the stock with a Buy and raised the price target from $101 to $106.

Considering buying MMSI stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.